News – Cumberland Pharmaceuticals

In The News

News

IV Form of NAC Receives FDA sNDA to Prevent, Lessen Liver Injury After Ingesting Toxic Quantities of Acetaminophen

December 10, 2024

New Dosing Regimen for APAP Overdose Antidote Acetadote Approved

December 10, 2024

Ibuprofen injection shows better real-world outcomes in comparative study

November 19, 2024

FDA Grants Orphan Drug Designation to lfetroban for Treatment of Duchenne Muscular Dystrophy-Associated Cardiomyopathy

November 08, 2024

Cumberland Pharmaceuticals granted Orphan Drug Designation and Rare Pediatric Disease Designation for lfetroban

November 07, 2024

CPIX: A Solid Stock With An Exciting Catalyst

May 31, 2023

Recent 2023 FDA Approvals

May 30, 2023

Caldolor gains FDA nod for infant treatment

May 30, 2023

Cumberland to launch Phase II trial of ifetroban for IPF

May 30, 2023

Nashville Post - In Charge

May 23, 2023

Cumberland Pharmaceuticals Celebrates New Corporate Headquarters

May 01, 2023

Tennessean – Lessons from COVID-19 Can Help US Fight Opioids

February 15, 2021

Nashville Medical News - Which Leaders Keep Music City 92 Billion Healthcare Industry Humming

January 29, 2021

LaunchTN – How CET is Bridging Innovative Healthcare Research and Entrepreneurship

January 27, 2021

Nashville Medical News – Introducing RediTrex, A New Methotrexate Delivery System

December 17, 2020

Nashville Medical News – Addressing Opioid Usage in the Hospital Setting

November 19, 2020

Infectious Disease Special Edition (IDSE) – Vibativ Sustained Activity Confirmed in Two Surveillance Studies

November 06, 2020

Pharmaceutical Industry’s Investment in Research, Development Paying Off

September 18, 2020

Orthopedics This Week - The Effort to Reduce Opioid Use Gets A Boost From New Drugs

September 14, 2020

COVID-19 Bacterial Pneumonia Virtual Expert Panel

May 11, 2020